These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2096493)
1. Chlorobutanol, a preservative of desmopressin, inhibits human platelet aggregation and release in vitro. Chen SL; Yang WC; Huang TP; Wann SA; Teng CM Thromb Haemost; 1990 Nov; 64(3):473-7. PubMed ID: 2096493 [TBL] [Abstract][Full Text] [Related]
2. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815 [TBL] [Abstract][Full Text] [Related]
4. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
5. Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets. Liao CH; Liao CH; Chang YL; Guh JH; Kuo SC; Huang LJ; Teng CM J Pharm Pharmacol; 2002 Jul; 54(7):967-74. PubMed ID: 12162716 [TBL] [Abstract][Full Text] [Related]
6. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910 [TBL] [Abstract][Full Text] [Related]
7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide. Han P; Boatwright C; Ardlie NG Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379 [TBL] [Abstract][Full Text] [Related]
10. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro. Wang LL; Mei QB; Zhao DH; Guo ZA Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670 [TBL] [Abstract][Full Text] [Related]
11. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. Rendu F; Bachelot C; Molle D; Caen J; Guez D J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063 [TBL] [Abstract][Full Text] [Related]
12. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists. Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144 [TBL] [Abstract][Full Text] [Related]
13. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010 [TBL] [Abstract][Full Text] [Related]
14. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom. Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053 [TBL] [Abstract][Full Text] [Related]
15. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity. Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative. Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558 [TBL] [Abstract][Full Text] [Related]
18. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
19. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]